PAVmed Inc. (PAVM)
Develops minimally invasive medical devices for diagnosing and treating conditions like carpal tunnel and esophageal cancer.
$5.38+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-65.8%
The outlook
PAVmed is trading well below both its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. Analyst coverage is sparse but shows a wide gap—the average price target implies significant upside, though current sentiment leans bearish overall. The stock remains thinly traded with mixed technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +569% vs current price
Analyst price target
~12-month · 2 analysts$36.00average target+569.1% vs now
Now $5.38
Low $16.00High $56.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$38.5M
52-wk high
$28.44
52-wk low
$3.85
50-day avg
$5.53
200-day avg
$8.89
Trailing P/E
—